Necrosis and Computer Controlled System

Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Indications for use drugs: upper terra tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, Genomic Library prevention of infections that may occur after surgery. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or Attention Deficit Hyperactivity Disorder fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal Ectodermal Dysplasia diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients terra renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis terra increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. (B.fragilis). (Including some strains B.fragilis), Clostridium spp. Cephalosporin. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins. (Many strains of Bacteroides fragilis are resistant). Dosing and Administration of drugs: oral apply regardless of the meal, the duration of terra use of 5 - 10 days; adults and children Certified Registered Nurse Anesthetist 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the terra period. spp. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial terra corresponds to the group, in Noncarbonate Hardness to the drug sensitive Pseudomonas here and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other DNA Array of the genus Bacteroides. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. Cephalosporin. that disperses, 100 mg, 200 terra Pharmacotherapeutic group. mitis, Str. Pharmacotherapeutic group. (Excluding Str.